title: Low circulating level of IGF-1 is a distinct indicator for the development of cardiovascular disease caused by combined hyperglycemia and dyslipidemia.
authors.affiliation: Institute of Cardiovascular Science & Department of Cardiovascular Surgery, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215123, PR China; Texas Heart Institute, Houston, TX 77030, USA. Electronic address: yangxin_li@yahoo.com.
authors.forename: Yangxin
authors.initials: Y
authors.lastname: Li
authors.affiliation: University of Texas Health Science Center, Houston, TX 77030, USA.
authors.forename: Harnath
authors.initials: H
authors.lastname: Shelat
authors.affiliation: University of Texas Health Science Center, Houston, TX 77030, USA.
authors.forename: Hanjing
authors.initials: H
authors.lastname: Wu
authors.affiliation: University of Texas Health Science Center, Houston, TX 77030, USA.
authors.forename: Mang
authors.initials: M
authors.lastname: Zhu
authors.affiliation: University of Texas Health Science Center, Houston, TX 77030, USA.
authors.forename: Jiaming
authors.initials: J
authors.lastname: Xu
authors.affiliation: Texas Heart Institute, Houston, TX 77030, USA; University of Texas Health Science Center, Houston, TX 77030, USA. Electronic address: yong-jian.geng@uth.tmc.edu.
authors.forename: Yong-Jian
authors.initials: YJ
authors.lastname: Geng
mesh_terms: D000818:Animals; D001057:Apolipoproteins E / Q000235:genetics; D002318:Cardiovascular Diseases / Q000209:etiology / Q000378:metabolism*; D003921:Diabetes Mellitus, Experimental / Q000150:complications / Q000378:metabolism*; D004195:Disease Models, Animal; D050171:Dyslipidemias / Q000150:complications / Q000378:metabolism*; D006943:Hyperglycemia / Q000150:complications / Q000378:metabolism*; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout
chemical_list: D001057:Apolipoproteins E; C519530:insulin-like growth factor-1, mouse; D007334:Insulin-Like Growth Factor I
keywords: Cardiovascular disease; Dyslipidemia; Hyperglycemia; IGF-1